Skip to content

Clinical trials

Recruiting Neoplasms by Site trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Status: Recruiting Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20191
20211
20222
20236
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK7
Astellas Pharma Global Development, Inc.1
Cogent Biosciences, Inc.1
Eli Lilly and Company1
Novartis Pharmaceuticals1
OncoSil Medical Limited1
Stemline Therapeutics, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms14
Neoplasms by Site14
Neoplasms by Histologic Type9
Hematologic Neoplasms7
Lymphoproliferative Disorders6
Carcinoma, Non-Small-Cell Lung4
Glioma4
Colorectal Neoplasms3
Melanoma3
Brain Neoplasms2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.